All UK & Rest of Europe articles – Page 56
-
NewsCall for papers for themed Pseudomonas collection in Letters in Applied Microbiology
The journal Letters in Applied Microbiology is to run a themed collection on ’Emerging Horizons in Pseudomonas Biotechnology – Innovations from Early-Career Researchers’.
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsAdvanced MRI technology detects changes in the brain after COVID-19
Researchers have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people.
-
NewsNovel compounds promise success in the fight against tuberculosis and depression
Scientists have shown that a specific polyprenylated polycyclic acylphloroglucinol, PPAP53, is able to activate human macrophages to fight resistant tuberculosis bacteria without being toxic to the macrophages themselves.
-
NewsScientists find new, better way to develop vaccines
Researchers have developed a new system to display epitopes in mammal cells for immunization studies and believe that this method can help scientists greatly in immunization efforts.
-
NewsCovid persistence in lungs linked to failure of innate immunity
A new study shows that SARS-CoV-2 is found in the lungs of certain individuals for up to 18 months after infection, and that its persistence appears to be linked to a failure of innate immunity (the first line of defense against pathogens).
-
NewsFirst results in using new tools to tackle respiratory syncytial virus
Vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent respiratory syncytial virus (RSV) among young children. Are those tools working?
-
News40 years after the discovery of HIV, research raises hopes of remission
The conference ’40 years of HIV science’ was an opportunity to look back at the major advances that are raising hopes of remission and a cure for HIV.
-
NewsNew study considers risks of colistin and carbapenem resistance posed by aquatic farms
Aquatic farms could serve as a potential reservoir of colistin and carbapenem resistance, a new study warns. The review, by researchers at the University of Manchester, ‘An Update on the Prevalence of Colistin and Carbapenem-Resistant Gram-Negative Bacteria in Aquaculture: an Emerging Threat to Public Health’, has been accepted by the ...
-
NewsUK funds £15.6 million boost for low-emission food production systems
Innovate UK and BBSRC are set to invest £15.6 million as part of the novel low-emission food production systems competition, backing 32 innovative projects that produce foods in a more environmentally friendly way.
-
NewsZinc shows promise as surprising emerging treatment for vaginal yeast infections
New research could one day pave the way for the treatment of vaginal yeast infections, by shedding new light on how microbes in the body absorb zinc.
-
NewsFungus-fighting protein could help overcome severe autoimmune disease and cancer
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease (IBS) and type 1 diabetes.
-
NewsResearchers redesign future mRNA therapeutics to prevent potentially harmful immune responses
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body, and have found a way to prevent ‘off-target’ immune responses.
-
NewsBacterial hijack mechanisms as advanced genetic tools
Researchers have uncovered the intricate molecular mechanism used by parasitic phytoplasma bacteria, known for inducing ‘zombie-like’ effects in plants.
-
NewsHIV drug could prevent coronaviruses, study finds
New research has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration.
-
NewsScientists explore bio-inspired membranes for separating contaminants from water
Scientists are to explore a more sustainable method of separating contaminants from water, using exquisite molecular selectivity, which means that just a single chemical or molecular species will be able to pass through the membrane.
-
NewsBroccoli molecule could shape immune defense against Cryptosporidium
Researchers have discovered that a common dietary supplement could protect against chronic Cryptosporidium infections which are particularly prevalent in children under two and in areas with poorer sanitation.
-
NewsDrug-resistant tuberculosis may be under-diagnosed, reveals genomic analysis
This genomic sequencing study, in southern Mozambique, is the first to characterise the drug resistance profile at the population level and identify mutations that escape routine diagnostic tests.
-
NewsU/EEA: HIV diagnoses rise for the first time in a decade
The increase in 2022 can be attributed to several factors including restoring surveillance activities, scale-up and introduction of novel testing strategies in many countries, migration patterns, lifting of COVID-19 restrictions and arrival of refugees.